168 related articles for article (PubMed ID: 23159852)
1. Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells.
Booher K; Lin DW; Borrego SL; Kaiser P
Cell Cycle; 2012 Dec; 11(23):4414-23. PubMed ID: 23159852
[TBL] [Abstract][Full Text] [Related]
2. S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1.
Lin DW; Chung BP; Kaiser P
J Cell Sci; 2014 Jan; 127(Pt 1):50-9. PubMed ID: 24155332
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells.
Borrego SL; Fahrmann J; Datta R; Stringari C; Grapov D; Zeller M; Chen Y; Wang P; Baldi P; Gratton E; Fiehn O; Kaiser P
Cancer Metab; 2016; 4():9. PubMed ID: 27141305
[TBL] [Abstract][Full Text] [Related]
4. Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells.
Zhao L; Wen ZH; Jia CH; Li M; Luo SQ; Bai XC
Anat Rec (Hoboken); 2011 Aug; 294(8):1337-43. PubMed ID: 21717584
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
Saqcena M; Patel D; Menon D; Mukhopadhyay S; Foster DA
Cell Cycle; 2015; 14(14):2285-92. PubMed ID: 25945415
[TBL] [Abstract][Full Text] [Related]
6. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
7. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
Lunn CL; Chrivia JC; Baldassare JJ
Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
[TBL] [Abstract][Full Text] [Related]
8. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
9. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
10. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression.
Hall BA; Kim TY; Skor MN; Conzen SD
Breast Cancer Res Treat; 2012 Sep; 135(2):469-79. PubMed ID: 22842983
[TBL] [Abstract][Full Text] [Related]
11. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines.
Stern PH; Wallace CD; Hoffman RM
J Cell Physiol; 1984 Apr; 119(1):29-34. PubMed ID: 6707100
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
13. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells.
Cave DD; Desiderio V; Mosca L; Ilisso CP; Mele L; Caraglia M; Cacciapuoti G; Porcelli M
J Cell Physiol; 2018 Feb; 233(2):1370-1383. PubMed ID: 28518408
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
Leung EY; Askarian-Amiri M; Finlay GJ; Rewcastle GW; Baguley BC
PLoS One; 2015; 10(7):e0131400. PubMed ID: 26148118
[TBL] [Abstract][Full Text] [Related]
15. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
[TBL] [Abstract][Full Text] [Related]
16. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
17. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
[TBL] [Abstract][Full Text] [Related]
18. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.
Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT
Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349
[TBL] [Abstract][Full Text] [Related]
19. Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma.
Ji WT; Yang SR; Chen JY; Cheng YP; Lee YR; Chiang MK; Chen HR
Cancer Sci; 2012 Jul; 103(7):1221-9. PubMed ID: 22469187
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
